About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 452709, 7 pages
http://dx.doi.org/10.1155/2013/452709
Clinical Study

Determinants of Thyrotoxic Cardiomyopathy Recovery

1Departamento de Ecocardiografía, Hospital de Especialidades de la Ciudad de México, Avenida Tláhuac 4866 Del Iztapalapa, 09700 México, DF, Mexico
2Departamento de Investigación Sociomédica, Instituto Nacional de Cardiología “Ignacio Chávez,” Juan Badiano No. 1, Col. Sección XVI, Del. Tlalpan, 14080 México, DF, Mexico
3Departamento de Endocrinología, Hospital Dr. Enrique Cabrera, Avenida Centenario Esquina Prolongación 5 de Mayo, Col ExHacienda de Tarango, Del Alvaro Obregón, 01618 México, DF, Mexico

Received 4 April 2013; Revised 14 June 2013; Accepted 18 July 2013

Academic Editor: Jeffrey L. Anderson

Copyright © 2013 Lucia Oliveros-Ruiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Cordova-Alvelais, J. Verdejo-Paris, and M. Cárdenas-Loaeza, “Serrano P. Cardiopatia tirotoxica,” Archivos de Cardiología de México, vol. 49, pp. 1046–1054, 1979.
  2. Y.-Y. Wang, B. Jiao, W.-G. Guo, H.-L. Che, and Z.-B. Yu, “Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes,” Molecular and Cellular Endocrinology, vol. 320, no. 1-2, pp. 67–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Cesarman and J. Rockey, “Cardiopatía hipertiroidea,” Archivos del Instituto de Cardiología de México, vol. I35, pp. 166–185, 1965.
  4. J. C. Forfar, D. M. Matthews, and A. D. Toft, “Delayed recovery of left ventricular function after antithyroid treatment. Further evidence for reversible abnormalities of contractility in hyperthyroidism,” British Heart Journal, vol. 52, no. 2, pp. 215–222, 1984. View at Scopus
  5. J. Mercé, S. Ferrás, C. Oltra, E. Sanz, J. Vendrell, and I. Simón, “Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler Echocardiographic study,” American Journal of Medicine, vol. 118, pp. 126–131, 2005.
  6. M. Sánchez-Carbayo, M. Mauri, R. Alfayate, C. Miralles, and F. Soria, “Analytical and clinical evaluation of TSH and thyroid hormones by electrochemiluminescent immunoassays,” Clinical Biochemistry, vol. 32, no. 6, pp. 395–403, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma et al., “ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography),” Circulation, vol. 108, no. 9, pp. 1146–1162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Breiman, J. H. Frieman, R. A. Olshen, and C. J. Stone, Classification and Regression Trees, Wadsworth International Group, Belmont, Cali, USA, 1984.
  9. C.-W. Siu, C.-Y. Yeung, C.-P. Lau, A. W. C. Kung, and H.-F. Tse, “Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism,” Heart, vol. 93, no. 4, pp. 483–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Iqbal, H. Schirmer, P. Lunde, Y. Figenschau, K. Rasmussen, and R. Jorde, “Thyroid stimulating hormone and left ventricular function,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 9, pp. 3504–3510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Wen Shen and C. Boon-Hor, “Hyperthyroidism-induced veft ventricular diastolic dysfunction; implication in hyperthyrodism-related heart failure,” Journal of Clinical Endocrinology and Metabolism, vol. 74, pp. 636–643, 2011.
  12. J. A. Sgarbi, F. G. Villaça, B. Garbeline, H. E. Villar, and J. H. Romaldini, “The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1672–1677, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Dörr, B. Wolff, D. M. Robinson et al., “The association of thyroid function with cardiac mass and left ventricular hypertrophy,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 2, pp. 673–677, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Nagarakanti, D. Whellan, S. Rubin, and P. J. Mather, “Reversible cardiomyopathies,” Cardiology in Review, vol. 15, no. 4, pp. 178–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Kaminski, D. Michalkiewicz, K. Makowski et al., “Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism,” Clinical Endocrinology, vol. 74, no. 4, pp. 501–507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. A. Smit, C. F. A. Eustatia-Rutten, E. P. M. Corssmit et al., “Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 6041–6047, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Basset, J. Blanc, E. Messas, A. Hagège, and J.-L. Elghozi, “Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study,” Journal of Cardiovascular Pharmacology, vol. 37, no. 2, pp. 163–172, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. E. N. Pearce, Q. Yang, E. J. Benjamin, J. Aragam, and R. S. Vasan, “Thyroid function and left ventricular structure and function in the framingham heart study,” Thyroid, vol. 20, no. 4, pp. 369–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. W.-S. Yue, B.-H. Chong, X.-H. Zhang et al., “Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure,” Clinical Endocrinology, vol. 74, no. 5, pp. 636–643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Frustaci, F. Loperfido, N. Gentiloni, M. Caldarulo, E. Morgante, and M. A. Russo, “Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia: a histologic, ultrastructural, and biochemical study,” Chest, vol. 99, no. 2, pp. 382–385, 1991. View at Scopus
  21. S. J. Lee, J. G. Kang, O. K. Ryu et al., “The relationship of thyroid hormone status with myocardial function in stress cardiomyopathy,” European Journal of Endocrinology, vol. 160, no. 5, pp. 799–806, 2009. View at Publisher · View at Google Scholar · View at Scopus